Bora CDMO Bora CDMO

X

CAS 61718-80-7 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 61718-80-7
Also known as: 61718-80-7, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one, 5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one, (4-methoxybutyl)(4-trifluoromethylphenyl)methanone, Fluvoxamine (ketone)
Molecular Formula
C13H15F3O2
Molecular Weight
260.25  g/mol
InChI Key
VYKSRLDHXQURKA-UHFFFAOYSA-N
FDA UNII
8D8A03845N

1 2D Structure

CAS 61718-80-7

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one
2.1.2 InChI
InChI=1S/C13H15F3O2/c1-18-9-3-2-4-12(17)10-5-7-11(8-6-10)13(14,15)16/h5-8H,2-4,9H2,1H3
2.1.3 InChI Key
VYKSRLDHXQURKA-UHFFFAOYSA-N
2.1.4 Canonical SMILES
COCCCCC(=O)C1=CC=C(C=C1)C(F)(F)F
2.2 Other Identifiers
2.2.1 UNII
8D8A03845N
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 61718-80-7

2. 5-methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone

3. 5-methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one

4. 5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one

5. (4-methoxybutyl)(4-trifluoromethylphenyl)methanone

6. Fluvoxamine (ketone)

7. 5-methoxy-4'-(trifluoromethyl)valerophenone

8. 5-methoxy-4-trifluoromethyl Valerophenone

9. 8d8a03845n

10. 1-pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-

11. 5-methoxy-1-(4-(trifluoromethyl)phenyl)-1-pentanone

12. 5-methoxy-1-[4-(trifluoromethyl)-phenyl]pentan-1-one

13. 1-pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-

14. Unii-8d8a03845n

15. Fluvoxamine Impurity D

16. Ec 425-000-1

17. Schembl2671567

18. Dtxsid60210724

19. Bcp10170

20. Mfcd06658173

21. Zinc16158744

22. Akos005064032

23. Ac-1407

24. Ps-7367

25. 5-methoxy-4'-trifluoromethylvalerophenone

26. Db-001107

27. Cs-0103012

28. Ft-0640783

29. C75897

30. Omega-methoxy-4'-(trifluoromethyl)valerophenone

31. 718m807

32. Fluvoxamine Maleate Impurity D [ep Impurity]

33. Q-101520

34. 5-methoxy-1-[4-(trifluoromethyl)-phenyl]-1-pentanone

35. Q27270215

36. 5-methoxy-4'-(trifluoromethyl)valerophenone Ketone

37. 5-methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one;fluvoxketone

38. Fluvoxamine Maleate Impurity, 5-methoxy-4'-(trifluoromethyl)valerophenone Ketone- [usp Impurity]

2.4 Create Date
2005-03-27
3 Chemical and Physical Properties
Molecular Weight 260.25 g/mol
Molecular Formula C13H15F3O2
XLogP33
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count5
Rotatable Bond Count6
Exact Mass260.10241420 g/mol
Monoisotopic Mass260.10241420 g/mol
Topological Polar Surface Area26.3 Ų
Heavy Atom Count18
Formal Charge0
Complexity256
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
URL Supplier Web Content
455-18-5
Fluvoxamine
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
17913-18-7
Fluvoxamine
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
61747-22-6
Fluvoxamine
ZCL Chemicals Ltd is an 100% Export Oriented Unit (EOU) that combines the power of science & technology. ...
ZCL Chemicals Ltd is an 100% Export Oriented Unit (EOU) that combines the power of science & technology. Established in 1991, the company head quarter is in Mumbai .The R&D Center and cGMP-manufacturing facility is in the Industrial heart of Ankleshwar city in Gujarat, 300 k.m. North of Mumbai, well connected by Road, Rail and Air enabling swift cargo movement to the nearest major sea/airport being Mumbai. The Company delivers a broad range of advance fine chemical intermediates and active.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY